Viewing Study NCT06892002


Ignite Creation Date: 2025-12-25 @ 3:39 AM
Ignite Modification Date: 2025-12-26 @ 2:23 AM
Study NCT ID: NCT06892002
Status: COMPLETED
Last Update Posted: 2025-08-15
First Post: 2025-01-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Description of Patients With Type 1 Diabetes Treated With Teplizumab
Sponsor: Sanofi
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2025-02-11
Start Date Type: ACTUAL
Primary Completion Date: 2025-08-05
Primary Completion Date Type: ACTUAL
Completion Date: 2025-08-05
Completion Date Type: ACTUAL
First Submit Date: 2025-01-24
First Submit QC Date: None
Study First Post Date: 2025-03-24
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-08-14
Last Update Post Date: 2025-08-15
Last Update Post Date Type: ACTUAL